Congenital leukemia presenting as fever in a neonate by Beard, Bethany & Turner, Joseph
 
 
This is the author's manuscript of the article published in final edited form as: 
 
Beard, B., & Turner, J. (2015). Congenital Leukemia Presenting as Fever in a Neonate. The Journal of Emergency 
Medicine, 48(6), e131–e133. http://doi.org/10.1016/j.jemermed.2015.01.011  
Congenital leukemia presenting as fever in a neonate 
Bethany Beard, MD and Joseph Turner, MD 
Emergency Department, Indiana University School of Medicine, Methodist Hospital, 
Indianapolis, Indiana 
Abstract 
Background: Emergency department workup of pediatric fever typically focuses on ruling out 
serious bacterial infection, but other disease processes can cause fever. Congenital leukemia is a 
rare but important cause of fever in neonates. We review the presentation, pathophysiology, and 
potential complications of congenital leukemia presenting to the emergency department as 
pediatric fever. 
Case Report: We report a case of a 4-week-old infant brought to the emergency department for 
fever and “not acting normally.” Complete blood count demonstrated hyperleukocytosis. 
Subsequent bone marrow biopsy and flow cytometry confirmed the diagnosis of congenital 
leukemia. The extreme elevation of the patient's white blood cell count put her at high risk for 
complications, necessitating aggressive treatment, close monitoring, and appropriate consultation 
for comprehensive care. 
Why Should an Emergency Physician Be Aware of This: Congenital leukemia is a rare but 
serious cause of neonatal fever. While the workup for fever without a source in young pediatric 
patients primarily focuses on ruling out serious bacterial illness, emergency physicians must be 
familiar with other potentially life-threatening causes of this complaint. 
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Introduction 
Fever is a common presenting complaint for pediatric patients in the emergency department, 
accounting for >10% of all visits 1, 2 and 3. Emergency department workup of pediatric fever 
typically focuses on ruling out serious bacterial infections through the use of age-based risk 
stratification and diagnostic algorithms 4, 5 and 6. However, a number of important 
noninfectious disease processes can also cause fever in young children 7 and 8. 
One rare but important consideration of neonatal fever is malignancy. Congenital leukemia 
develops while the fetus is in utero and presents within the first 4 weeks of life. The diagnosis of 
congenital leukemia depends on three major criteria: the presence of immature hematopoietic 
cells in peripheral blood and bone marrow, hematopoietic cell infiltration into nonhematopoietic 
tissue (ie, skin), and exclusion of other conditions in the differential diagnosis (9). This condition 
has an estimated incidence of <5 per 1 million births (10). We report a rare case of congenital 
leukemia presenting to the emergency department as pediatric fever. 
Case Report 
A 4-week-old African-American female presented to the emergency department with parental 
concerns of fever and “not acting normally.” Her mother noticed decreased activity from her 
baseline, although she did have good oral intake and urinary output. Earlier in the day, the 
patient had a measured temperature of 101.5°F. 
 
The patient was born at 39 + 5 weeks. The pregnancy was complicated by untreated maternal 
group B streptococcus infection and nonactive genital herpes at the time of delivery. The patient 
was delivered via cesarean section due to persistent decelerations in her heart rate and 
intolerance to labor. After the delivery, the newborn did well and was discharged home under the 
care of her mother and father. 
The patient presented to the emergency department on the day her fever began. On examination, 
she had a heart rate of 155 beats/min, respiratory rate of 30 breaths/min, temperature of 37.0°C, 
and oxygen saturation of 100%. She was alert and well appearing, had normal respiratory effort 
and clear breath sounds, no cardiac murmur with normal femoral pulses, and no 
lymphadenopathy or hepatosplenomegaly. Her abdomen was soft and nondistended and she had 
no skin abnormalities, such as petechiae, bruising, or rash. She also had a strong suck with a 
pacifier, normal muscle tone, and movement of all four extremities. 
The newborn's examination in the emergency department was normal; however, given the 
findings of fever without a source in this age group, a full septic workup was initiated, including 
a complete blood count, urinalysis with urine culture, blood culture, and lumbar puncture. The 
infant was started on empiric ampicillin, cefotaxime, and acyclovir. Laboratory results revealed a 
white blood cell count of 370,000 k/mm3 with 86% blasts, hemoglobin 7.6 g/dL, and platelet 
count of 44,000 k/mm3. Leukemia was strongly suspected; however, further differential 
diagnosis of hyperleukocytosis includes transient myeloproliferative disease associated with 
Down syndrome, congenital infections, hemolytic diseases with leukamoid reaction, and other 
congenital neoplasms, such as neuroblastoma (10). Additional workup was initiated through 
consultation with pediatric oncology, including uric acid level, lactate dehydrogenase, basic 
metabolic panel, and ionized calcium to evaluate for tumor lysis syndrome. All additional 
laboratory results returned normal except an elevated lactate dehydrogenase of 1,795 U/L. The 
patient did not have tumor lysis syndrome at the time of emergency department presentation and 
she was ultimately transferred to the associated children's hospital. 
On the morning after hospital admission, the newborn underwent bone marrow biopsy. 
Cytogenetic results revealed 46XX, t(4; 11) (q21; 23). She was diagnosed with infant B-cell 
acute lymphocytic leukemia, which was later confirmed by flow cytometry. She remained under 
the care of a pediatric oncologist and received 1 week of prednisone for induction therapy via 
protocol AALL-0631 with vincristine, daunorubicin, cytarabine, asparaginase, hydrocortisone 
intrathecal, methotrexate intrathecal, and dexamethasone. 
Discussion 
The clinical presentation of congenital leukemia is quite rare and variable. Hepatosplenomegaly 
is one of the most frequently encountered signs on physical examination, being noted in 80% of 
cases (10). Splenomegaly is present in 74% of cases (11). Lymphadenopathy is observed only 
one-quarter of the time (10). Patients can also present with other signs and symptoms commonly 
found in diseases of the bone marrow, including pallor, petechiae, ecchymosis, and abnormal 
bleeding. Failure to thrive, pleural effusions, and neurologic manifestations have been reported, 
but are much less common 10 and 11. 
A classic manifestation of congenital leukemia is infiltration of leukemic cells into the skin 
referred to as leukemia cutis. These lesions appear as diffuse palpable violaceous nodules and, 
when observed, should alert the medical provider to underlying malignancy (9). Leukemia cutis 
is more frequently observed in acute myelogenous leukemia and is rare in acute lymphoblastic 
leukemia (9). Reports on the frequency of this finding in congenital leukemia range from 30% to 
60% 9 and 10. 
Approximately 70% of neonatal leukemias are associated with cytogenetic disorders, most 
commonly with rearrangement of the mixed lineage leukemia (MLL) gene (11q23). 
Translocation of this gene gives rise to fusion proteins that increase leukemogenesis and 
hematopoiesis (9). The neonate in this case had 46 XX(4;11)(q21;23) translocation, which is 
associated with an aggressive MLL. This particular gene rearrangement is observed in > 60% of 
infants with acute lymphocytic leukemia (ALL) and portends a very poor prognosis 12 and 13. 
The presence of an MLL gene rearrangement and age < 6 months are the most important factors 
predicting poor prognosis, followed by a white blood cell count > 300,000 k/mm3 and poor 
response to prednisone (9). Neonates diagnosed with congenital leukemia frequently become 
refractory to treatment and often die within the first year of life (9). 
Leukemia can present with significant leukocytosis and predispose the patient to two severe 
conditions: thrombosis and tumor lysis syndrome. Initial treatment goals are to avoid such 
complications by limiting blood viscocity and hyperuricemia from cell destruction. Further 
emergency department care includes correction of electrolyte abnormalities, including 
hyperkalemia, ensuring adequate hydration, and treatment of hyperuricemia and coagulation 
imbalances (14). The patient in this case was at risk for both emergencies, given the severity of 
her leukocytosis (>300,000 k/mm3). 
Hyperleukocytosis is seen in 10% to 30% of patients with newly diagnosed ALL (15). High 
leukemic cell burden increases blood viscosity and causes white blood cell plugging, referred to 
as leukostasis. The combination of these clinical states increases the risk of strokes. Blast cells 
also contain pro-coagulant substances that further propagate clot formation and risk of infarction 
(14). Although leukemic patients may present with anemia, it is important to avoid blood 
transfusion if possible, as this will further increase blood viscosity. Hyperleukocytosis is 
primarily treated with induction chemotherapy to decrease the white blood cell count and target 
leukemic cells in the bone marrow. The neonate in this case began treatment with intravenous 
fluids at twice her maintenance rate to decrease blood viscocity, prevent renal damage, and dilute 
excess electrolytes. 
Leukemic patients undergoing cytoreduction with chemotherapy are at risk of tumor lysis 
syndrome. This condition occurs due to the destruction of blasts spontaneously or after 
treatment. Destroyed cells release potassium, phosphate, and uric acid into the serum. Elevated 
uric acid levels can damage renal tubules and lead to subsequent organ failure. The neonate in 
this case began early treatment with allopurinol to limit uric acid levels. The addition of sodium 
bicarbonate to fluids can also help to alkalinize the urine and decrease uric acid crystal 
deposition (14). Patients with high blood cell destruction might also experience hyperkalemia; 
therefore, it is important to exclude potassium from intravenous fluid regimens. An 
electrocardiogram should be obtained early, as hyperkalemia can lead to fatal dysrhythmias. 
Hyperkalemia in leukemia is treated with standard therapies, including calcium gluconate, 
insulin, glucose, and beta-agonists. 
In cases of newly diagnosed leukemia where tumor lysis or hyperviscocity syndrome might 
present, it is important to involve a multidisciplinary care team including pediatric oncology, 
nephrology, and intensive care for further support and treatment recommendations. 
Why Should an Emergency Physician Be Aware of This? 
 
This case is an example of a common emergency department complaint resulting from a rare 
disease process. The workup and diagnostic approach to neonates with fever is well standardized 
and directed toward ruling out serious bacterial infections. This case demonstrates the 
importance of considering not only infectious etiologies, but also hematologic and oncologic 
diseases as the cause of fever. Such hematologic disorders can result in life-threatening 
conditions that the emergency physician must recognize and treat, including hyperleukocytosis 
and tumor lysis syndrome, electrolyte imbalances, and organ damage with subsequent failure. 
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